JP2011520466A5 - - Google Patents

Download PDF

Info

Publication number
JP2011520466A5
JP2011520466A5 JP2011510512A JP2011510512A JP2011520466A5 JP 2011520466 A5 JP2011520466 A5 JP 2011520466A5 JP 2011510512 A JP2011510512 A JP 2011510512A JP 2011510512 A JP2011510512 A JP 2011510512A JP 2011520466 A5 JP2011520466 A5 JP 2011520466A5
Authority
JP
Japan
Prior art keywords
seq
residues
luciferase
amino acid
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011510512A
Other languages
English (en)
Japanese (ja)
Other versions
JP6110591B2 (ja
JP2011520466A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/003132 external-priority patent/WO2009142735A2/en
Publication of JP2011520466A publication Critical patent/JP2011520466A/ja
Publication of JP2011520466A5 publication Critical patent/JP2011520466A5/ja
Application granted granted Critical
Publication of JP6110591B2 publication Critical patent/JP6110591B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011510512A 2008-05-19 2009-05-19 ｃＡＭＰのためのルシフェラーゼバイオセンサー Active JP6110591B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US5437408P 2008-05-19 2008-05-19
US61/054,374 2008-05-19
US11998308P 2008-12-04 2008-12-04
US61/119,983 2008-12-04
PCT/US2009/003132 WO2009142735A2 (en) 2008-05-19 2009-05-19 LUCIFERASE BIOSENSORS FOR cAMP

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014266438A Division JP6275635B2 (ja) 2008-05-19 2014-12-26 ｃＡＭＰのためのルシフェラーゼバイオセンサー

Publications (3)

Publication Number Publication Date
JP2011520466A JP2011520466A (ja) 2011-07-21
JP2011520466A5 true JP2011520466A5 (enExample) 2016-10-27
JP6110591B2 JP6110591B2 (ja) 2017-04-05

Family

ID=41202867

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2011510512A Active JP6110591B2 (ja) 2008-05-19 2009-05-19 ｃＡＭＰのためのルシフェラーゼバイオセンサー
JP2014266438A Active JP6275635B2 (ja) 2008-05-19 2014-12-26 ｃＡＭＰのためのルシフェラーゼバイオセンサー

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2014266438A Active JP6275635B2 (ja) 2008-05-19 2014-12-26 ｃＡＭＰのためのルシフェラーゼバイオセンサー

Country Status (5)

Country Link
US (2) US9045730B2 (enExample)
EP (1) EP2281046B1 (enExample)
JP (2) JP6110591B2 (enExample)
AT (1) ATE542903T1 (enExample)
WO (1) WO2009142735A2 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2298902B1 (en) 2003-10-10 2015-04-22 Promega Corporation Luciferase biosensor
JP5684984B2 (ja) 2006-04-03 2015-03-18 プロメガ コーポレイションＰｒｏｍｅｇａ Ｃｏｒｐｏｒａｔｉｏｎ 順列置換及び非順列置換ルシフェラーゼバイオセンサー
ATE542903T1 (de) 2008-05-19 2012-02-15 Promega Corp Luciferase-biosensoren für camp
KR101665352B1 (ko) * 2009-05-01 2016-10-12 프로메가 코포레이션 광 출력이 향상된 합성 오플로포러스 루시퍼라제
US9290794B2 (en) 2010-05-11 2016-03-22 Promega Corporation Mutant protease biosensors with enhanced detection characteristics
EP2569423B1 (en) 2010-05-11 2015-12-02 Promega Corporation Mutant protease biosensors with enhanced detection characteristics
AU2011323418B2 (en) 2010-11-02 2017-07-27 Promega Corporation Novel coelenterazine substrates and methods of use
EP2635583B1 (en) 2010-11-02 2015-06-03 Promega Corporation Coelenterazine derivatives and methods of using same
WO2012071631A1 (en) * 2010-12-03 2012-06-07 Gene Stream Pty Ltd Improved light-emitting molecules
EP2825887A4 (en) 2012-03-15 2015-08-19 Montana Molecular Llc GENETICALLY-CODED, FLUORESCENT SENSORS FOR THE DETECTION OF INTRA-CELLULAR SIGNALS BY DIACYLGLYCEROL SIGNAL PATHS
JP2015000021A (ja) * 2013-06-14 2015-01-05 浜松ホトニクス株式会社 細胞内ｃＡＭＰ濃度を制御する方法
JP6484987B2 (ja) 2013-10-21 2019-03-20 Jnc株式会社 エビルシフェラーゼの触媒蛋白質の変異遺伝子とその使用法
CA2929392A1 (en) 2013-11-04 2015-05-07 Montana Molecular Llc Genetically encoded fluorescent sensors for detecting ligand bias and intracellular signaling through camp pathways
US9927430B2 (en) 2014-01-29 2018-03-27 Promega Corporation Pro-substrates for live cell applications
JP6703484B2 (ja) 2014-01-29 2020-06-03 プロメガ コーポレイションＰｒｏｍｅｇａ Ｃｏｒｐｏｒａｔｉｏｎ 細胞による取り込み測定のための、標識用試薬としての、キノンでマスクされたプローブ
JP6265020B2 (ja) 2014-04-16 2018-01-24 Jnc株式会社 エビルシフェラーゼの触媒蛋白質の変異遺伝子とその使用法
US10316070B2 (en) 2016-09-09 2019-06-11 Promega Corporation Dual protected pro-coelenterazine substrates
WO2020050208A1 (ja) * 2018-09-05 2020-03-12 ヤマサ醤油株式会社 Ｔｓｈ受容体に対する自己抗体活性の迅速測定方法及びキット
KR20220002883A (ko) * 2019-03-12 2022-01-07 퀴델 코포레이션 자가항체 검출용 조성물, 키트, 및 방법
US20210318292A1 (en) * 2020-04-13 2021-10-14 Sensorium Bio, Inc. System and Method to Detect Small Molecules
US20240174992A1 (en) 2022-05-04 2024-05-30 Promega Corporation Split modified dehalogenase variants
JP2025515179A (ja) 2022-05-04 2025-05-13 プロメガ コーポレイション 円順列置換デハロゲナーゼバリアント
WO2025100444A1 (ja) * 2023-11-07 2025-05-15 株式会社コスミックコーポレーション Ｔｓｈ活性測定用のレポーター細胞

Family Cites Families (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO864301L (no) * 1986-10-28 1988-04-29 Tore Jahnsen Dna-prober for human regulatorisk enhet av camp-avhengige proteinkinaser.
WO1990005745A1 (en) * 1988-11-18 1990-05-31 The General Hospital Corporation A cAMP-RESPONSIVE TRANSCRIPTIONAL ENHANCER BINDING PROTEIN
US5683888A (en) * 1989-07-22 1997-11-04 University Of Wales College Of Medicine Modified bioluminescent proteins and their use
GB8916806D0 (en) 1989-07-22 1989-09-06 Univ Wales Medicine Modified proteins
FR2682122B1 (fr) 1991-10-03 1995-06-09 Pasteur Institut Nouveaux genes d'helicobacter pylori. leur utilisation pour la preparation de souches recombinantes de h. pylori.
DE69535744T2 (de) 1994-01-03 2009-07-02 Promega Corp., Madison Mutierte luziferasen
CA2196496A1 (en) * 1997-01-31 1998-07-31 Stephen William Watson Michnick Protein fragment complementation assay for the detection of protein-protein interactions
US6294330B1 (en) * 1997-01-31 2001-09-25 Odyssey Pharmaceuticals Inc. Protein fragment complementation assays for the detection of biological or drug interactions
US7312302B2 (en) 1997-02-20 2007-12-25 Oncolmmunin, Inc. Compositions for the detection of enzyme activity in biological samples and methods of use thereof
US6037137A (en) 1997-02-20 2000-03-14 Oncoimmunin, Inc. Fluorogenic peptides for the detection of protease activity
US6602677B1 (en) * 1997-09-19 2003-08-05 Promega Corporation Thermostable luciferases and methods of production
JP4537573B2 (ja) * 1997-09-19 2010-09-01 プロメガ・コーポレイシヨン 熱安定ルシフェラーゼと生産方法
US6342611B1 (en) * 1997-10-10 2002-01-29 Cytovia, Inc. Fluorogenic or fluorescent reporter molecules and their applications for whole-cell fluorescence screening assays for capsases and other enzymes and the use thereof
US6884870B2 (en) 1998-03-20 2005-04-26 California Institute Of Technology Fusion proteins for identifying proteases, protease target sites and regulators of protease activity in living cells
US6855515B1 (en) 1998-04-22 2005-02-15 Merck & Co., Inc. Autoantigenic fragments, methods and assays
GB9819666D0 (en) 1998-09-09 1998-11-04 Univ Aberdeen Biosensor
US20020192719A1 (en) * 1998-09-30 2002-12-19 Caliper Technologies Corp. Homogeneous assay methods
WO2000024768A2 (en) 1998-10-23 2000-05-04 Massachusetts Institute Of Technology Genes integrating signal transduction pathways
GB9823468D0 (en) 1998-10-28 1998-12-23 Secr Defence Novel enzyme
US6670144B1 (en) * 1999-02-26 2003-12-30 Cyclacel, Ltd. Compositions and methods for monitoring the phosphorylation of natural binding partners
JP3059435B1 (ja) * 1999-03-18 2000-07-04 扶桑薬品工業株式会社 ｃＡＭＰおよびアデニル酸シクラ―ゼの酵素的蛍光定量アッセイ
US6573059B1 (en) * 1999-06-04 2003-06-03 Rmf Dictagene S.A. Use of the regulatory subunit of the camp dependent protein kinase (PKA) from dictyostelium for camp measurements
US7109315B2 (en) * 2000-03-15 2006-09-19 Bruce J. Bryan Renilla reniformis fluorescent proteins, nucleic acids encoding the fluorescent proteins and the use thereof in diagnostics, high throughput screening and novelty items
US6808874B2 (en) * 2000-06-13 2004-10-26 Cyclacel Ltd. Methods of monitoring enzyme activity
US6890745B1 (en) 2000-07-19 2005-05-10 Chemicon International, Inc. Protease specific cleavable luciferases and methods of use thereof
US7166447B2 (en) * 2000-07-26 2007-01-23 Japan Science And Technology Corporation Probe for analyzing protein—protein interaction and method of analyzing protein—protein interactions with the use of the same
US6541196B2 (en) * 2000-07-26 2003-04-01 Jackson State University Method for cAMP production
US7879540B1 (en) 2000-08-24 2011-02-01 Promega Corporation Synthetic nucleic acid molecule compositions and methods of preparation
US20020073441A1 (en) 2000-12-13 2002-06-13 Ross Brian D. Compositions and methods for detecting proteolytic activity
US7083911B2 (en) * 2001-02-16 2006-08-01 Promega Corporation Method for detection of ATP
US20030053995A1 (en) 2001-06-15 2003-03-20 Mien-Chie Hung Methods and compositions for inhibiting EGF receptor activity
AU2002364124A1 (en) 2001-11-28 2003-06-10 The Burnham Institute Methods for identifying modulators of apoptosis
US7927871B2 (en) 2002-01-29 2011-04-19 Oncoimmunin, Inc. Visualization and quantitation of cellular cytotoxicity using cell-permeable fluorogenic protease substrates and caspase activity indicator markers
AU2003216207A1 (en) 2002-02-08 2003-09-02 The Regents Of The University Of California A transcription amplification system for molecular imaging
US6730492B2 (en) * 2002-03-09 2004-05-04 Merrimack Pharmaceuticals, Inc. Cell-based screening methods
US20030170850A1 (en) * 2002-03-09 2003-09-11 Cardone Michael H. Cell-based screening methods
EP2218790A3 (en) * 2002-09-06 2010-08-25 Promega Corporation Kits for detecting transferase enzymatic activity
GB0221915D0 (en) 2002-09-20 2002-10-30 Skeland Stein O D Assay
WO2004038039A2 (en) 2002-10-21 2004-05-06 The Regents Of The University Of California Optical imagiong of renilla luciferase reporter gene expression in living organisms
WO2004043992A2 (en) 2002-11-08 2004-05-27 The Regents Of The University Of California Imaging protein-protein interactions in living subjects
JP4485470B2 (ja) * 2002-12-23 2010-06-23 プロメガ コーポレイション ルシフェラーゼ酵素活性を保護するための方法及びキット
US7524674B2 (en) 2003-03-07 2009-04-28 Stanford University Multimodality imaging of reporter gene expression using a novel fusion vector in living cells and animals
CA2445420A1 (en) * 2003-07-29 2005-01-29 Invitrogen Corporation Kinase and phosphatase assays
US7619059B2 (en) * 2003-07-29 2009-11-17 Life Technologies Corporation Bimolecular optical probes
US7442518B2 (en) 2003-08-06 2008-10-28 Washington University Imaging regulated protein-protein interactions in cells and living animals by enhanced luciferase protein fragment complementation
US7488583B2 (en) * 2003-09-25 2009-02-10 Odyssey Thera, Inc. Fragment complementation assays for G-protein-coupled receptors and their signaling pathways
EP2298902B1 (en) * 2003-10-10 2015-04-22 Promega Corporation Luciferase biosensor
EP1536020A1 (en) 2003-11-26 2005-06-01 Bayerische Julius-Maximilians-Universität Würzburg Means and methods for optical determination of cAMP in vitro and in vivo
US20060110364A1 (en) 2004-08-20 2006-05-25 Ludwig Institute For Cancer Research Vector-mediated delivery of polynucleotides encoding soluble VEGF receptors
EP1791972A4 (en) 2004-08-23 2009-12-02 Univ Johns Hopkins cAMP REPORTER
US20060048592A1 (en) * 2004-09-09 2006-03-09 Ung Tom T Damping nut for screw-driven mechanism
CA2619686A1 (en) * 2005-08-19 2007-02-22 Commomwealth Scientific And Industrial Research Organisation Arachnocampa luciferases
JP5684984B2 (ja) * 2006-04-03 2015-03-18 プロメガ コーポレイションＰｒｏｍｅｇａ Ｃｏｒｐｏｒａｔｉｏｎ 順列置換及び非順列置換ルシフェラーゼバイオセンサー
CN103230598A (zh) 2006-09-06 2013-08-07 费斯生物制药公司 融合肽治疗组合物
US7812002B2 (en) 2007-03-21 2010-10-12 Quark Pharmaceuticals, Inc. Oligoribonucleotide inhibitors of NRF2 and methods of use thereof for treatment of cancer
EP2154159A4 (en) 2007-05-09 2012-03-21 Univ Tokyo INDICATOR FOR ACTIVATED PROTEASE
WO2009049892A1 (en) 2007-10-17 2009-04-23 European Molecular Biology Laboratory (Embl) Polypeptides comprising an annexin core domain, compositions, methods and use thereof
EP2215227A2 (en) * 2007-11-05 2010-08-11 Promega Corporation Hybrid fusion reporter and uses thereof
WO2009140662A1 (en) * 2008-05-15 2009-11-19 Illumina, Inc. Engineered luciferases
ATE542903T1 (de) 2008-05-19 2012-02-15 Promega Corp Luciferase-biosensoren für camp
EP2569423B1 (en) 2010-05-11 2015-12-02 Promega Corporation Mutant protease biosensors with enhanced detection characteristics
JP5501862B2 (ja) 2010-05-24 2014-05-28 株式会社サンユー 金属被膜見本キット
AU2011323418B2 (en) 2010-11-02 2017-07-27 Promega Corporation Novel coelenterazine substrates and methods of use
EP2776573A1 (en) 2011-11-11 2014-09-17 Promega Corporation Mutant protease biosensors with enhanced detection characteristics

Similar Documents

Publication Publication Date Title
JP2011520466A5 (enExample)
JP6275635B2 (ja) ｃＡＭＰのためのルシフェラーゼバイオセンサー
US11932680B2 (en) CD8A-binding fibronectin type III domains
Brown et al. Functional coupling of mammalian receptors to the yeast mating pathway using novel yeast/mammalian G protein α‐subunit chimeras
Krylov et al. Extending dimerization interfaces: the bZIP basic region can form a coiled coil.
JP2010536327A5 (enExample)
Altincicek et al. Interaction of the corepressor Alien with DAX-1 is abrogated by mutations of DAX-1 involved in adrenal hypoplasia congenita
JP2018050556A (ja) 嗅覚受容体共受容体
RU2016149596A (ru) Новые полипептиды со специфическим связыванием и пути их применения
JP2014502149A5 (enExample)
JP2012530690A (ja) 変異体タンパク質およびそれらを生産する方法
JP2018519802A5 (enExample)
JP2022531244A (ja) Ｇｐｃｒに結合する化合物及びリガンドをスクリーニングするためのキメラタンパク質及び方法
Milovnik et al. Selection and characterization of DARPins specific for the neurotensin receptor 1
Vitko et al. Orientation of the calcium channel β relative to the α12. 2 subunit is critical for its regulation of channel activity
WO2000071743A1 (fr) Methode bihybride dans une cellule de mammifere
JP4361684B2 (ja) エリトロポエチン受容体のためのペプチドリガンド
KR20220151176A (ko) 혈중 콜레스테롤 저하용, 심혈관 대사질환의 예방 또는 치료용 및 항염용 약학적 조성물
JP2017037014A5 (enExample)
ES2288770T3 (es) Region c-terminal de proteina de transcrito relacionado con aguti (art).
KR20230174589A (ko) 비타민 관련 바이오 복합체에 특이적으로 결합하는 펩타이드 및 이의 용도
WO2001092302A2 (en) Human cyslt2 nucleic acids, polypeptides, and uses thereof
JP7025041B2 (ja) 変異が導入された甲状腺刺激ホルモン受容体
WO2018200814A2 (en) Modified cyclic peptides and therapeutic use thereof
CN114456261A (zh) 抗sars-cov-2病毒s蛋白rbd结构域的纳米抗体及其用途